Breakthrough in Cancer Treatment by Indian Scientists: In a groundbreaking development, Indian scientists have achieved remarkable success in the fight against cancer, offering a new ray of hope to patients. The news of a patient being successfully cured of cancer through Indian therapy has instilled immense confidence among the citizens. The CR-T Cell Therapy has played a pivotal role in this significant advancement, paving the way for a new era in cancer treatment.
CR-T Cell Therapy is instrumental in elevating the battle against cancer to unprecedented levels. Using this innovative technology, doctors have devised an effective way to completely restore patients suffering from various forms of the disease. The success of this therapy has prompted government initiatives to boost research and development in this crucial field. The newfound hope against life-threatening diseases like cancer is enhancing the possibility of healthier lives for patients.
Developed in collaboration with the Indian Institutes of Technology Bombay (IITB), IIT-B, and Tata Memorial Hospital, the NexCAR19 and ImmunoACT therapies have opened new doors in cancer treatment. This therapy has shown efficacy against B-cell cancers such as leukemia and lymphoma, receiving commercial approval from the CDSEIO. Currently available in 30 hospitals across 10 cities in India, this therapy is making strides in treating cancer patients aged 15 years and above.
This innovative approach has not only transformed the landscape of cancer treatment but has also led to advancements on the global stage. The therapy, now accessible in India, is providing cancer patients with not only a more economically viable option but also a new lease on life. Dr. V.K. Gupta, a gastroenterologist in Delhi, shared that the cost of this therapy for him is only 4.2 million INR, compared to over 40 million INR for the same treatment abroad.
The success of CR-T Cell Therapy showcases a significant transformation in the medical and technological landscape of India. It proves that the country is making strides in providing world-class treatments, offering not just financial relief but also a path to a new and healthier life for those battling cancer.
Understanding CR-T Cell Therapy
CR-T Cell Therapy, also known as CAR-T (Chimeric Antigen Receptor T-cell) Therapy, is a revolutionary method in treating blood cancers like leukemia and B-cell lymphomas. In this technique, the patient’s white blood cells, particularly T-cells, are extracted and genetically modified to enhance their ability to combat cancer. These modified cells are then reintroduced into the patient’s body, rejuvenating their immune system to effectively fight against cancer. This process, known as apheresis, involves modifying the T-cells to express chimeric antigen receptors (CARs), creating what is termed CAR-T cells. This controlled procedure is conducted in specialized laboratories to ensure safety.
CAR-T Cell Therapy has proven to be a game-changer, especially for patients who had previously undergone unsuccessful treatments. It is emerging as an effective and safe alternative, providing new hope to individuals fighting cancer. The successful implementation of this therapy at Apollo Group hospitals in India has benefited 16 patients so far, marking a significant milestone in cancer treatment in the country.
While the cost of this treatment might be a concern, it represents a major step forward in the medical field in India. The therapy requires patients to be closely monitored for weeks post-treatment, ensuring their health is supported and the treatment progresses optimally.
The development and successful application of CR-T Cell Therapy by Apollo hospitals signify a paradigm shift in India’s medical prowess. This new therapeutic approach is not only economically viable but is also providing cancer patients with renewed prospects for a healthier and cancer-free life.